弥漫性血管内凝血
败血症
医学
血栓性血小板减少性紫癜
疾病
发病机制
凝结
血小板减少性紫癜
器官功能障碍
免疫学
血小板
重症监护医学
病理
内科学
作者
Toshiaki Iba,Eizo Watanabe,Yutaka Umemura,Takeshi Wada,Kei Hayashida,Shigeki Kushimoto,Hideo Wada
标识
DOI:10.1186/s40560-019-0387-z
摘要
Disseminated intravascular coagulation (DIC) is a common complication in sepsis. Since DIC not only promotes organ dysfunction but also is a strong prognostic factor, its diagnosis at the earliest possible timing is important. Thrombocytopenia is often present in patients with DIC but can also occur in a number of other critical conditions. Of note, many of the rare thrombocytopenic diseases require prompt diagnoses and specific treatments. To differentiate these diseases correctly, the phenotypic expressions must be considered and the different disease pathophysiologies must be understood. There are three major players in the background characteristics of thrombocytopenia: platelets, the coagulation system, and vascular endothelial cells. For example, the activation of coagulation is at the core of the pathogenesis of sepsis-associated DIC, while platelet aggregation is the essential mechanism in thrombotic thrombocytopenic purpura and endothelial damage is the hallmark of hemolytic uremic syndrome. Though each of the three players is important in all thrombocytopenic diseases, one of the three dominant players typically establishes the individual features of each disease. In this review, we introduce the pathogeneses, symptoms, diagnostic measures, and recent therapeutic advances for the major diseases that should be immediately differentiated from DIC in sepsis.
科研通智能强力驱动
Strongly Powered by AbleSci AI